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Abstract CIN85 and CMS belong to a family of ubiquitously
expressed adaptor molecules containing three SH3 domains, a
proline-rich region and a coiled-coil domain. By binding to nu-
merous proteins they assemble multimeric complexes implicated
in cell-speci¢c signals controlling T-cell activation, kidney glo-
meruli function or apoptosis in neuronal cells. CIN85/CMS also
associate with accessory endocytic proteins, components of the
actin cytoskeleton as well as other adaptor proteins involved in
receptor tyrosine kinase (RTK) signaling. These interactions
enable CIN85/CMS to function within a network of signaling
pathways that co-ordinate critical steps involved in downregula-
tion and degradation of RTKs. . 2002 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Adaptor molecules are non-catalytic polypeptides that con-
tain one or more domains able to bind to other protein or
non-protein ligands [1]. These molecules selectively control the
spatial and temporal assembly of multiprotein complexes that
transmit intracellular signals involved in regulation of cell
growth, di¡erentiation, migration and survival [1]. The impor-
tance of such signaling networks is well understood for signal
transduction induced by receptor tyrosine kinases (RTKs) [2].
Binding of growth factors to RTKs promotes receptor activa-
tion leading to autophosphorylation and phosphorylation of
numerous cellular proteins. This initiates a cascade of pro-
tein^protein interactions and formation of signaling networks
that mediate proliferative and di¡erentiating signals [1,2]. Ac-
tivation of RTKs also leads to their rapid removal from the
cell surface in a process dependent on receptor ubiquitination
and dynamic interaction with accessory endocytic proteins [3].
For example, Cbl, a ubiquitin ligase, binds to and ubiquiti-
nates activated RTKs and also recruits CIN85^endophilin
complexes to mediate receptor internalization [4^6]. Once in-
ternalized, RTKs are delivered into the endosomal compart-
ment where receptors get sorted for either recycling back to
the cell surface or targeting to lysosomes for degradation [3].
This review describes a recently identi¢ed family of adaptor
proteins known as the CIN85/CMS family that is involved in
orchestrating multiple steps in RTK signaling and endocyto-
sis.
2. Identi¢cation and structure of CIN85 and CD2-associated
protein (CD2AP)
CIN85 was independently identi¢ed as Cbl-interacting pro-
tein of 85 kDa [7], Ruk (regulator of ubiquitous kinase) [8],
SETA (SH3 domain-containing gene expressed in tumorigenic
astrocytes) [9] and SH3KBP1 (SH3 domain kinase binding
protein 1) [10]. These genes were isolated from either human
(CIN85), rat (Ruk and SETA) or mouse (SH3KBP1) sources
and share between 92% and 97% sequence identity, suggesting
that they represent homologues of one gene. Since CIN85 was
the ¢rst gene cloned we have used this name throughout the
review. The CIN85 gene is localized on the distal arm of the
X chromosome (Xp22.1^p21.3) in mouse [10]. A main 3.2 kb
CIN85 mRNA is expressed in all adults and newborn tissues
[7,8,11]. Due to alternative splicing and di¡erent promoter
usage, multiple CIN85 mRNA messages have been detected,
which showed a more restricted pattern of expression [8,11].
Another adaptor protein known as CD2AP [12], CMS (Cas
ligand with multiple SH3 domains) [13] or METS-1 (mesen-
chyme-to-epithelium transition protein with SH3 domains)
[14] displays high sequence and structural similarities to
CIN85. CMS was cloned from human placenta by its ability
to interact with p130Cas [13], while CD2AP/METS-1, a
mouse homologue of CMS, was identi¢ed by binding to the
adhesion receptor CD2 or as a gene strongly induced during
kidney development, respectively [12,14]. The CMS gene is
localized on chromosome 6 (6p12) in humans. A prominent
5.4 kb CMS mRNA is ubiquitously expressed in adult and
fetal human tissues [13].
The overall domain organization of CIN85 and CMS/
CD2AP is identical and they share 39% identity and 54%
similarity in amino acid sequence (Fig. 1). At the amino-ter-
minus CIN85 and CMS/CD2AP contain three SH3 domains
known to mediate protein^protein interactions by binding to
proline-rich motifs. These three SH3 domains share higher
similarity among themselves than to any other SH3 domains,
suggesting that they may have overlapping speci¢cities in
binding. A region rich in serine and threonine residues, which
could be subject to phosphorylation, lies between the second
and third SH3 domains. There are also three FxDxF sequen-
ces in the amino-terminus that may serve as binding sites for
the clathrin adaptor protein AP2 [15]. A proline-rich region is
found adjacent to the third SH3 domain of CIN85/CMS,
providing potential recognition sites for other SH3 domain-
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containing proteins. The carboxyl-terminal half of these pro-
teins is predicted to be globular, and the last 50 amino acid
residues show high propensity for coiled-coil structure.
Coiled-coil structures are implicated in homotypic and hetero-
typic protein interactions [16]. In addition, CMS, but not
CIN85, contains four putative actin binding sites in its car-
boxyl-terminus that are similar to the LKKTET motifs found
in a number of actin binding proteins [13].
Due to their sequence and structural similarities CIN85 and
CMS/CD2AP form a new family of adaptor proteins. Since
CIN85 and CMS are the names of the human genes, this
family was designated CIN85/CMS. Interestingly, the
CIN85/CMS family is not phylogenetically conserved as there
are no CIN85/CMS orthologues found in Drosophila mela-
nogaster, Caenorhabditis elegans or yeast.
3. Proteins interacting with CIN85 and CMS
There is a rapidly growing list of proteins reported to in-
teract with CIN85 and CMS (Table 1). Most of them were
isolated using a yeast two-hybrid system and were subse-
quently con¢rmed for their interactions in vivo. Several
groups have shown that the SH3 domains of CIN85 or
CMS directly bind to members of the Cbl family of ubiquitin
ligases [6,7,17], CD2 receptors [9,12], B-cell linker protein
BLNK [18], apoptosis regulator AIP1 [11] and SETA binding
protein SB1 [9]. The optimal binding site for SH3 domains of
CIN85/CMS has not yet been determined. The ¢rst SH3 do-
main of CMS speci¢cally binds to the type II PxxP motif
present in the CD2 receptor [12]. On the other hand, multiple
SH3 domains of CIN85/CMS are required for binding to the
distal carboxyl-terminus of Cbl [6,7,17]. Interestingly, their
binding was increased following tyrosine phosphorylation of
Cbl in cells stimulated with growth factors [6,7,17], suggesting
that phosphorylation of Cbl induces a conformational change
of the protein, thereby unmasking putative SH3 binding mo-
tifs able to interact with CIN85/CMS. In accordance, the
association of CMS with CD2 receptor was also induced
upon T-cell activation [12]. Therefore, interactions between
SH3 domains of the CIN85/CMS family and their targets
Fig. 1. Schematic representation of the domain structure of CIN85 and CMS. CIN85 and CMS contain three N-terminal SH3 domains, a cen-
trally located proline-rich motif and a C-terminal coiled-coil domain. CMS additionally contains four actin binding motifs at the C-terminus.
Alternative splice forms of CIN85 lack one or two SH3 domains or contain only the isolated coiled-coil domain. CIN85/CMS proteins were
isolated in human, rat and mouse, while there are no orthologues found in D. melanogaster, C. elegans or yeast cells.
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may be regulated in the cell by ligand stimulations. This is a
novel characteristic of SH3 domain binding since it is gener-
ally believed that SH3 domains bind constitutively to poly-
proline motifs. There are currently no available data on
whether interactions between CIN85 and BLNK, SB1 or
AIP1 are also inducible by external signals [9,11,18,19].
More recently, a minimal binding domain in the distal part
of Cbl and Cbl-b that is necessary for association with CIN85
was identi¢ed [20]. Interestingly, binding of CIN85 to this
domain is not mediated via classical PxxP motifs [20]. Iden-
ti¢cation of the consensus binding motif for the CIN85/CMS
SH3 domains and structural determination of their interac-
tions would provide a molecular explanation for the mecha-
nism by which CIN85 and CMS act as inducible sca¡olding
proteins.
Numerous SH3 domain-containing proteins were shown to
be constitutively associated with proline-rich regions of
CIN85/CMS (Table 1). Many of these proteins including
Grb2, p130Cas, Crk and p85 phosphatidyl inositol-3 (PI-3)
kinase are adaptor molecules linked to protein tyrosine kinase
pathways [8,9,13,18]. CIN85 binding to the SH3 domain of
the p85 PI-3 kinase inhibits its kinase activity and may thus
block PI-3 kinase survival pathways in neuronal cells [8].
CMS was also shown to bind to Src family kinases and to
co-localize with p130Cas in membrane ru¥es and leading
edges of cells ; these interactions were implicated in dynamic
regulation of the actin cytoskeleton [13]. More recently, two
independent groups have shown that the endophilin family of
accessory endocytic proteins constitutively binds to CIN85
and mediates internalization of RTKs. [5,6]. The interaction
was mediated by the SH3 domain of endophilin bound to
PKKPPPP and PKKPRPP motifs present in a proline-rich
region of CIN85/CMS [5]. CIN85 and CMS were also shown
to be homodimerized via their coiled-coil domains [9,13,18].
Finally, there is a list of kidney-speci¢c proteins including
nephrin, podocin and polycistin-2 that associate with the car-
boxyl-terminus of CMS [14,19,21,22].
4. Receptor clustering and formation of immunological synapse
The original discovery of CD2AP indicated its role in CD2
receptor clustering and cytoskeletal polarity in the contact
area between T-cells and antigen-presenting cells [12]. This
specialized junctional structure is conceptually analogous to
a neuronal synapse and is called ‘immunological synapse’ [12].
Biochemical studies have indicated that the ¢rst SH3 domain
of CD2AP binds to a single polyproline motif found in the
carboxyl-terminal tail of CD2 and that their association is
increased after T-cell engagement [12]. CD2AP was proposed
to cluster CD2 receptors leading to organization of the im-
munological synapse [12]. However, it is not yet understood
how CD2AP can mediate clustering of CD2 receptors if one
CD2AP binds to only one CD2 receptor. One plausible ex-
planation is that CD2AP is homo-oligomerized (due to coiled-
coil interactions) and that CD2 receptor phosphorylation may
lead to a conformational change in its carboxyl-terminal tail,
thus favoring binding of CD2AP proteins that could in turn
aggregate CD2 receptors. Another likely scenario is that all
three SH3 domains of CD2AP may bind to the CD2 molecule
enabling one CD2AP to cluster three CD2 receptors. The ¢rst
SH3 domain of CD2AP binds with high a⁄nity to a polypro-
line peptide in CD2 receptors, while it has not been tested
whether the other two SH3 domains can also bind to the
same peptide with similar or di¡erent a⁄nities [12]. Moreover,
CIN85 also binds to CD2 and is highly expressed in T-cells
indicating that both proteins may have redundant roles in
controlling CD2 function in the immunological synapse [9].
5. Building kidney architecture
A similar role for CD2AP was proposed in clustering a
kidney-speci¢c nephrin receptor [19,23]. Nephrin and CD2
are both immunoglobulin superfamily receptors involved in
organization of specialized cell adhesive structures called slit
diaphragm in podocytes and immunological synapse in
T-cells, respectively [12,19]. An interacting network of clus-
tered nephrin molecules is believed to be critical for glomer-
ular ¢ltration via the slit diaphragm. Nephrin binds to
CD2AP and co-localizes with CD2AP in the slit diaphragm
area [19,21,24]. A novel domain in the carboxyl-terminus of
CD2AP was shown to associate with the cytoplasmic portion
of nephrin [21]. Both proteins are also present in lipid rafts as
well as linked to the actin cytoskeleton [23]. It was suggested
that the main function of CD2AP is to anchor nephrin to the
cytoskeleton, while other associated proteins may be involved
in their clustering [19]. For example, a sca¡olding protein
Table 1
CIN85/CMS binding partners
Protein Interacts with Function Reference
c-Cbl SH3-ABC of CIN85/CMS Downregulation of RTKs [6,7,17]
Cbl-b SH3-ABC of CIN85 Downregulation of RTKs [20]
BLNK: B-cell linker protein SH3-ABC of CIN85 B-cell receptor signaling [18]
SB1 (similar to NY-REN-45) SH3-ABC of CIN85 Not yet de¢ned [9]
CD2 SH3-B of CD2AP and CIN85 T-cell receptor clustering. T-cell polarization [9,12]
AIP1/Alix SH3-B of CIN85 Apoptosis in glial cells [11]
p85 subunit of PI-3 kinase Proline-rich region of CIN85 Negative regulation of PI-3 kinase. Induction of
apoptosis in neuronal cells
[8]
Grb2 Proline-rich region of CIN85 Regulation of RTK signaling [9,13,18]
p130Cas Proline-rich region of CMS/CIN85 Regulation of the actin cytoskeleton [13,18]
Fyn, Src, Yes, Proline-rich region of CMS Regulation of Src family kinases [13]
Endophilins A1, A2 and A3 Proline-rich region of CIN85 Regulation of RTK internalization [5,6]
Nephrin CD2AP C-terminus Structural organization of kidney podocytes [19,21]
Polycystin-2 CMS/CD2AP C-terminus Maintenance of renal tubular structure [14]
Podocin CD2AP Kidney glomerular architecture [22]
CIN85/CMS Coiled-coil region of CIN85/CMS Homodimerization of CIN85/CMS [9,13,18]
K-ear of AP2 FxDxF region of CIN85/CMS Regulation of clathrin-mediated endocytosis [15]
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podocin is present in high-order oligomers in lipid rafts of the
slit diaphragm and associates with both CD2AP and nephrin,
thus promoting their aggregation [22]. Functional signi¢cance
of these interactions is emphasized by phenotypes observed in
CD2AP-de¢cient mice. They exhibited gross defects in glo-
meruli function leading to a premature death from renal fail-
ure [19]. T-cell proliferation and functions were also severely
impaired [19]. In accordance, mutations in the nephrin gene
cause a congenital nephrotic syndrome in humans [25].
CD2AP binds also to polycystin-2, a large transmembrane
protein thought to be involved in cell^matrix adhesions as
well as ion channel functions [14]. Taken together, it appears
that interactions of CD2AP with nephrin, podocin and poly-
cystin-2 may play important roles in building kidney architec-
ture and maintaining its specialized functions.
6. Receptor endocytosis
Downregulation of RTKs is a critical step in modulating
their activity [3]. This is a highly ordered and dynamic process
controlled by the assembly of a large network of RTK-asso-
ciated proteins as well as their post-translational modi¢cations
including phosphorylation and ubiquitination [3]. The Cbl
family of ubiquitin ligases plays a major role in receptor ubiq-
uitination, receptor sorting for degradation and ultimately in
cessation of receptor-induced signal transduction [4].
Several lines of evidence support a role of CIN85/CMS in
the regulation of Cbl-directed RTK downregulation (Fig. 2).
CIN85 and CMS are rapidly recruited in Cbl^RTK complexes
after growth factor stimulation [5,6,17,20]. In that way,
CIN85 positions pre-associated endophilins in close proximity
Fig. 2. Proposed role of CIN85/CMS in RTK endocytosis. I : Upon ligand-induced activation of EGF receptors, Cbl binds to phosphorylated
receptors and promotes receptor ubiquitination (Ubi). Cbl is also tyrosine-phosphorylated in this complex leading to translocation of CIN85/en-
dophilin in the vicinity of active EGF receptors, whereby endophilins in concert with dynamin and amphiphysin regulate clathrin-mediated in-
ternalization. II: CIN85 and CMS are also monoubiquitinated by Cbl in these complexes and are implicated in sorting of EGF receptors along
the endocytic pathway for lysosomal degradation.
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of internalizing receptors [5,6]. Endophilins are regulatory
components of clathrin-coated vesicle that could induce neg-
ative curvature and invagination of the plasma membrane
during the early steps of RTK internalization [26^28]. This
appears to be a general mechanism involved in internalization
of multiple RTKs, including EGFR, PDGFR, c-Met and
c-Kit [5,6,20]. CIN85/CMS may have additional roles in link-
ing Cbl^RTK complexes with clathrin-coated endocytosis.
One possible pathway, although not yet proven, includes
binding of the AP2-K subunit appendage (K-ear) to FxDxF
motifs found in the amino-termini of both CIN85 and CMS
[15]. Di¡erent subunits of the AP2 adaptor complex bind to
either internalization motifs found in RTKs, or to clathrin
and accessory endocytic proteins [15]. It is possible that the
dual binding of AP2 adaptor complex to RTKs and to
CIN85/CMS may provide higher avidity interactions neces-
sary to target and recruit preferentially activated RTKs into
clathrin-coated vesicles.
The role of CIN85 in regulation of RTK downregulation is
not only speci¢c for clathrin-mediated internalization, but
also participates in post-internalization processes such as en-
docytic tra⁄cking and receptor degradation. CIN85 is co-lo-
calized with Cbl and activated RTKs in post-clathrin vesicles
[5,6,20]. CIN85 is also targeted for common degradation with
Cbl and EGFR in the lysosome [29]. Interestingly, CMS and
CIN85 are monoubiquitinated by Cbl and Cbl-b in a trimeric
complex with activated EGF receptors [29]. Monoubiquitina-
tion of proteins is a critical signal for endosomal sorting of
proteins into multivesicular bodies and their targeting for deg-
radation [30]. Several proteins involved in receptor endocyto-
sis, including Eps15, Hrs and epsins, are monoubiquitinated
following EGF stimulation [31]. Monoubiquitination of
CIN85/CMS may therefore be a signal for their sorting to
the lysosome, while non-ubiquitinated CIN85/CMS are re-
cycled back to the cytoplasm [29]. More direct evidence for
the role of CIN85 and CMS in regulating endosome functions
is provided by data showing that overexpression of CIN85
and CMS leads to the formation of multiple vesicles in the
cell [13,18]. These vesicles contain several markers of the en-
dosomal compartment as well as Cbl and p130Cas proteins
([13] and Szymkiewicz and Dikic, unpublished data). Interest-
ingly, deletion of the coiled-coil domain of CIN85 or CMS is
su⁄cient to impair the formation of these vesicles ([13,18] and
Szymkiewicz and Dikic, unpublished data). A coiled-coil fold
exists in many endocytic proteins such as Hrs, epsins, Eps15,
sorting nexins and others [16,32^34]. Similarly, deletion of
coiled-coil domains in Hrs and sorting nexin 1 blocks the
formation of endocytic vesicles upon overexpression of the
respective proteins [32,33]. Although these results suggest
that the coiled-coil domain of CIN85 is involved in sorting
processes in the endosome, the molecular mechanism of its
action is not yet understood. Cbl and CIN85/CMS are
homo-oligomerized via their leucine zipper or coiled-coil do-
mains, respectively [18,35]. Therefore, the increase in local
concentrations of Cbl- and CIN85/CMS-anchored signaling
complexes in the proximity of activated receptors may provide
spatial and temporal co-ordination of critical steps in receptor
endocytosis. The process of cargo delivery along the endo-
some may require polarization of vesicles as well as dynamic
actin reorganization [36,37]. By its ability to bind both recep-
tor cargo complex as well as components of the actin cyto-
skeleton CIN85/CMS may co-ordinate cross-talk between en-
docytic vesicles and the actin cytoskeleton. CIN85/CMS could
also cluster and target Cbl^RTK complexes to one side of
vesicles, thus providing sorting signals. This dual mode of
action is similar to the role CMS plays in clustering of CD2
and nephrin receptors and anchoring them to specialized ad-
hesion structures. This suggests a general mechanism by which
CIN85 and CMS regulate functions of transmembrane recep-
tors.
7. Conclusions and perspective
The CIN85/CMS family of adaptor proteins is an evolu-
tionary divergent family of adaptor molecules with speci¢c
functions in higher eukaryotes. They are involved in forma-
tion of kidney glomeruli architecture, organization of special-
ized junctions in T-cells called immunological synapse and co-
ordinating multiple steps in endocytosis of RTKs. A common
mode of action has been revealed whereby CIN85/CMS pro-
teins may regulate these processes by clustering transmem-
brane receptors and mediating dynamic interactions with the
actin cytoskeleton. It will be interesting to test if CIN85/CMS
play similar roles in organizing synapses or promoting synap-
tic vesicle endocytosis in neuronal cells. In the near future, we
can expect a growing list of CIN85/CMS-interacting proteins
that may provide a better understanding of their roles in reg-
ulation of endosome tra⁄cking.
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